nodes	percent_of_prediction	percent_of_DWPC	metapath
Nilotinib—CDC42BPB—smooth muscle tissue—appendix cancer	0.0252	0.0252	CbGeAlD
Nilotinib—MAPK8—epithelium—appendix cancer	0.0236	0.0236	CbGeAlD
Nilotinib—MAPK8—smooth muscle tissue—appendix cancer	0.0228	0.0228	CbGeAlD
Nilotinib—TIE1—epithelium—appendix cancer	0.0205	0.0205	CbGeAlD
Nilotinib—TIE1—smooth muscle tissue—appendix cancer	0.0197	0.0197	CbGeAlD
Nilotinib—FRK—endocrine gland—appendix cancer	0.0195	0.0195	CbGeAlD
Nilotinib—MAPK11—female gonad—appendix cancer	0.0178	0.0178	CbGeAlD
Nilotinib—CDC42BPB—female gonad—appendix cancer	0.0177	0.0177	CbGeAlD
Nilotinib—CDC42BPB—endocrine gland—appendix cancer	0.0164	0.0164	CbGeAlD
Nilotinib—MAPK8—female gonad—appendix cancer	0.016	0.016	CbGeAlD
Nilotinib—MAPK14—epithelium—appendix cancer	0.015	0.015	CbGeAlD
Nilotinib—MAPK8—endocrine gland—appendix cancer	0.0148	0.0148	CbGeAlD
Nilotinib—EPHA6—endocrine gland—appendix cancer	0.0148	0.0148	CbGeAlD
Nilotinib—MAPK14—smooth muscle tissue—appendix cancer	0.0145	0.0145	CbGeAlD
Nilotinib—EPHB4—epithelium—appendix cancer	0.0142	0.0142	CbGeAlD
Nilotinib—EPHA2—epithelium—appendix cancer	0.0139	0.0139	CbGeAlD
Nilotinib—TIE1—female gonad—appendix cancer	0.0138	0.0138	CbGeAlD
Nilotinib—LYN—endocrine gland—appendix cancer	0.0137	0.0137	CbGeAlD
Nilotinib—EPHB4—smooth muscle tissue—appendix cancer	0.0137	0.0137	CbGeAlD
Nilotinib—TEK—epithelium—appendix cancer	0.0136	0.0136	CbGeAlD
Nilotinib—BRAF—female gonad—appendix cancer	0.0133	0.0133	CbGeAlD
Nilotinib—EPHB3—female gonad—appendix cancer	0.0132	0.0132	CbGeAlD
Nilotinib—TEK—smooth muscle tissue—appendix cancer	0.0131	0.0131	CbGeAlD
Nilotinib—BLK—lymph node—appendix cancer	0.013	0.013	CbGeAlD
Nilotinib—HCK—female gonad—appendix cancer	0.0121	0.0121	CbGeAlD
Nilotinib—ABL2—female gonad—appendix cancer	0.012	0.012	CbGeAlD
Nilotinib—PDGFRA—smooth muscle tissue—appendix cancer	0.0119	0.0119	CbGeAlD
Nilotinib—MAPK11—lymph node—appendix cancer	0.0114	0.0114	CbGeAlD
Nilotinib—CDC42BPB—lymph node—appendix cancer	0.0113	0.0113	CbGeAlD
Nilotinib—HCK—endocrine gland—appendix cancer	0.0113	0.0113	CbGeAlD
Nilotinib—EPHA4—female gonad—appendix cancer	0.011	0.011	CbGeAlD
Nilotinib—EPHA3—lymph node—appendix cancer	0.0108	0.0108	CbGeAlD
Nilotinib—CSF1R—smooth muscle tissue—appendix cancer	0.0105	0.0105	CbGeAlD
Nilotinib—MAPK8—lymph node—appendix cancer	0.0103	0.0103	CbGeAlD
Nilotinib—EPHA4—endocrine gland—appendix cancer	0.0102	0.0102	CbGeAlD
Nilotinib—MAPK14—female gonad—appendix cancer	0.0101	0.0101	CbGeAlD
Nilotinib—CA3—endocrine gland—appendix cancer	0.0101	0.0101	CbGeAlD
Nilotinib—FGR—female gonad—appendix cancer	0.0101	0.0101	CbGeAlD
Nilotinib—LCK—female gonad—appendix cancer	0.0101	0.0101	CbGeAlD
Nilotinib—KIT—epithelium—appendix cancer	0.00985	0.00985	CbGeAlD
Nilotinib—CA9—endocrine gland—appendix cancer	0.00967	0.00967	CbGeAlD
Nilotinib—PDGFRB—epithelium—appendix cancer	0.00963	0.00963	CbGeAlD
Nilotinib—EPHB4—female gonad—appendix cancer	0.00961	0.00961	CbGeAlD
Nilotinib—KIT—smooth muscle tissue—appendix cancer	0.0095	0.0095	CbGeAlD
Nilotinib—MAPK14—endocrine gland—appendix cancer	0.00943	0.00943	CbGeAlD
Nilotinib—EPHA2—female gonad—appendix cancer	0.00943	0.00943	CbGeAlD
Nilotinib—FGR—endocrine gland—appendix cancer	0.00939	0.00939	CbGeAlD
Nilotinib—MAP4K1—lymph node—appendix cancer	0.00933	0.00933	CbGeAlD
Nilotinib—PDGFRB—smooth muscle tissue—appendix cancer	0.00927	0.00927	CbGeAlD
Nilotinib—TEK—female gonad—appendix cancer	0.0092	0.0092	CbGeAlD
Nilotinib—EPHB4—endocrine gland—appendix cancer	0.00894	0.00894	CbGeAlD
Nilotinib—TIE1—lymph node—appendix cancer	0.0089	0.0089	CbGeAlD
Nilotinib—EPHB6—female gonad—appendix cancer	0.00879	0.00879	CbGeAlD
Nilotinib—EPHA2—endocrine gland—appendix cancer	0.00877	0.00877	CbGeAlD
Nilotinib—TEK—endocrine gland—appendix cancer	0.00855	0.00855	CbGeAlD
Nilotinib—BRAF—lymph node—appendix cancer	0.00853	0.00853	CbGeAlD
Nilotinib—EPHB3—lymph node—appendix cancer	0.00846	0.00846	CbGeAlD
Nilotinib—PDGFRA—female gonad—appendix cancer	0.00833	0.00833	CbGeAlD
Nilotinib—ABL1—smooth muscle tissue—appendix cancer	0.00827	0.00827	CbGeAlD
Nilotinib—HCK—lymph node—appendix cancer	0.00778	0.00778	CbGeAlD
Nilotinib—PDGFRA—endocrine gland—appendix cancer	0.00775	0.00775	CbGeAlD
Nilotinib—ABL2—lymph node—appendix cancer	0.00773	0.00773	CbGeAlD
Nilotinib—MAP2K5—female gonad—appendix cancer	0.00752	0.00752	CbGeAlD
Nilotinib—UGT1A1—endocrine gland—appendix cancer	0.00739	0.00739	CbGeAlD
Nilotinib—CSF1R—female gonad—appendix cancer	0.00734	0.00734	CbGeAlD
Nilotinib—CA12—endocrine gland—appendix cancer	0.00715	0.00715	CbGeAlD
Nilotinib—EPHA4—lymph node—appendix cancer	0.00707	0.00707	CbGeAlD
Nilotinib—MAP2K5—endocrine gland—appendix cancer	0.00699	0.00699	CbGeAlD
Nilotinib—CA3—lymph node—appendix cancer	0.00698	0.00698	CbGeAlD
Nilotinib—CSF1R—endocrine gland—appendix cancer	0.00682	0.00682	CbGeAlD
Nilotinib—KIT—female gonad—appendix cancer	0.00666	0.00666	CbGeAlD
Nilotinib—MAPK14—lymph node—appendix cancer	0.00652	0.00652	CbGeAlD
Nilotinib—PDGFRB—female gonad—appendix cancer	0.00651	0.00651	CbGeAlD
Nilotinib—FGR—lymph node—appendix cancer	0.00649	0.00649	CbGeAlD
Nilotinib—LCK—lymph node—appendix cancer	0.00649	0.00649	CbGeAlD
Nilotinib—KIT—endocrine gland—appendix cancer	0.0062	0.0062	CbGeAlD
Nilotinib—EPHB4—lymph node—appendix cancer	0.00618	0.00618	CbGeAlD
Nilotinib—EPHA2—lymph node—appendix cancer	0.00606	0.00606	CbGeAlD
Nilotinib—PDGFRB—endocrine gland—appendix cancer	0.00605	0.00605	CbGeAlD
Nilotinib—TEK—lymph node—appendix cancer	0.00591	0.00591	CbGeAlD
Nilotinib—CA2—epithelium—appendix cancer	0.00584	0.00584	CbGeAlD
Nilotinib—ABL1—female gonad—appendix cancer	0.0058	0.0058	CbGeAlD
Nilotinib—CA1—endocrine gland—appendix cancer	0.00567	0.00567	CbGeAlD
Nilotinib—EPHB6—lymph node—appendix cancer	0.00565	0.00565	CbGeAlD
Nilotinib—CA2—smooth muscle tissue—appendix cancer	0.00563	0.00563	CbGeAlD
Nilotinib—ABL1—endocrine gland—appendix cancer	0.00539	0.00539	CbGeAlD
Nilotinib—PDGFRA—lymph node—appendix cancer	0.00536	0.00536	CbGeAlD
Nilotinib—MAP2K5—lymph node—appendix cancer	0.00483	0.00483	CbGeAlD
Nilotinib—CA4—female gonad—appendix cancer	0.00476	0.00476	CbGeAlD
Nilotinib—CSF1R—lymph node—appendix cancer	0.00472	0.00472	CbGeAlD
Nilotinib—CA4—endocrine gland—appendix cancer	0.00443	0.00443	CbGeAlD
Nilotinib—KIT—lymph node—appendix cancer	0.00428	0.00428	CbGeAlD
Nilotinib—PDGFRB—lymph node—appendix cancer	0.00418	0.00418	CbGeAlD
Nilotinib—CA2—female gonad—appendix cancer	0.00395	0.00395	CbGeAlD
Nilotinib—CA1—lymph node—appendix cancer	0.00392	0.00392	CbGeAlD
Nilotinib—ABL1—lymph node—appendix cancer	0.00373	0.00373	CbGeAlD
Nilotinib—CA2—endocrine gland—appendix cancer	0.00367	0.00367	CbGeAlD
Nilotinib—ABCG2—female gonad—appendix cancer	0.00366	0.00366	CbGeAlD
Nilotinib—CYP2C8—endocrine gland—appendix cancer	0.0035	0.0035	CbGeAlD
Nilotinib—CYP2B6—endocrine gland—appendix cancer	0.00314	0.00314	CbGeAlD
Nilotinib—CYP2C9—endocrine gland—appendix cancer	0.00311	0.00311	CbGeAlD
Nilotinib—CA4—lymph node—appendix cancer	0.00306	0.00306	CbGeAlD
Nilotinib—ABCB1—epithelium—appendix cancer	0.00267	0.00267	CbGeAlD
Nilotinib—CA2—lymph node—appendix cancer	0.00254	0.00254	CbGeAlD
Nilotinib—CYP2D6—female gonad—appendix cancer	0.00251	0.00251	CbGeAlD
Nilotinib—CYP3A4—endocrine gland—appendix cancer	0.00237	0.00237	CbGeAlD
Nilotinib—ABCG2—lymph node—appendix cancer	0.00235	0.00235	CbGeAlD
Nilotinib—CYP2D6—endocrine gland—appendix cancer	0.00233	0.00233	CbGeAlD
Nilotinib—ABCB1—female gonad—appendix cancer	0.0018	0.0018	CbGeAlD
Nilotinib—ABCB1—endocrine gland—appendix cancer	0.00168	0.00168	CbGeAlD
Nilotinib—ABCB1—lymph node—appendix cancer	0.00116	0.00116	CbGeAlD
